Showing 2911-2920 of 4275 results for "".
- New Anatomy-Based Framework Targets Prevention of GLP-1 RA-Associated Facial Aginghttps://modernaesthetics.com/news/new-anatomy-based-framework-targets-prevention-of-glp-1-ra-associated-facial-aging/2487408/A conceptual model published online ahead of print in Aesthetic Plastic Surgery proposes an anatomy-driven approach to identifying and preventing facial aging changes associated with glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, commonly referred to as “Ozempic face.”
- Review Examines Glycation’s Expanding Role in Cutaneous Aginghttps://modernaesthetics.com/news/review-examines-glycations-expanding-role-in-cutaneous-aging/2487357/A narrative review published in the Journal of Cosmetic Dermatology examines the growing evidence linking glycation and advanced glycation end products (AGEs) to skin aging, highlighting potential implications for both dermatology and aesthetic medicine. In the review, Diala Hayka
- FDA Clears Caliway’s Phase 3 CBL-514 Trial for Abdominal Fat Reductionhttps://modernaesthetics.com/news/fda-clears-caliways-phase-3-cbl-514-trial-for-abdominal-fat-reduction/2487183/Caliway Biopharmaceuticals announced that the US Food and Drug Administration (FDA) cleared the Investigational New Drug application for CBL-0302, also known as SUPREME-02, its second global pivotal phase 3 study of CBL-514 for abdominal subcutaneous fat reduction.1 The IND pass
- LaserAway Marks 20 Years with Continued National Expansionhttps://modernaesthetics.com/news/laseraway-marks-20-years-with-continued-national-expansion/2487069/LaserAway is celebrating its 20th anniversary alongside continued national expansion and recent recognition within the aesthetics industry. The company, which specializes in aesthetic dermatology services, announced that it now operates more than 215 clinics across the United States. The c
- Review Examines Dermatologic Effects of Rapid Weight Losshttps://modernaesthetics.com/news/review-examines-dermatologic-effects-of-rapid-weight-loss/2486984/Rapid weight loss associated with bariatric surgery, glucagon-like peptide-1 receptor agonists (GLP-1 RA), and intensive lifestyle interventions may contribute to dermatologic and structural changes that extend beyond reduced body size, according to a narrative rev
- Dr. Kevin Pinski Presents Injectable Pearls at Noahhttps://modernaesthetics.com/news/dr-kevin-pinski-presents-injectable-pearls-at-noah/2486902/At the 67th Noah Worcester Dermatological Society Annual Meeting, Kevin Pinski, MD, presented “Injectable Pearls,” drawing on nearly 4 decades of experience with neuromodulators, fillers, and cosmetic injectables. The presentation covered practical techniques, pati
- Review Charts Anatomically Driven Advances in East Asian Rhinoplastyhttps://modernaesthetics.com/news/review-charts-anatomically-driven-advances-in-east-asian-rhinoplasty/2486869/A recent review published online in Journal of Craniofacial Surgery examines the evolution of nasal tip rhinoplasty in East Asia, highlighting a transition from imported Western techniques to regionally tailored innovations grounded in anatomic and cultural considerations. Nasal t
- Allergan Aesthetics Launches Fourth Year of The Confidence Collectivehttps://modernaesthetics.com/news/allergan-aesthetics-launches-fourth-year-of-the-confidence-collective/2486549/Allergan Aesthetics, an AbbVie company, has opened applications for the fourth year of The Confidence Collective, a BOTOX® Cosmetic-branded initiative focused on supporting women entrepreneurs, according to company-provided materials. The application window is open through April 29, 20
- Case Report Describes Dual-Phase CL Code for Facial Rejuvenationhttps://modernaesthetics.com/news/case-report-describes-dual-phase-cl-code-for-facial-rejuvenation/2486484/A case report in the April 2026 issue of Journal of Cosmetic Dermatology described a dual-phase injectable approach to facial rejuvenation that combined contour restoration with ligamentous support using a polycaprolactone-based collagen stimulator. The authors termed the method the “CL
- AAD 2026: Acclaro to Highlight Expanding Clinical Uses of UltraClear 2910 nm Fiber Laserhttps://modernaesthetics.com/news/aad-2026-acclaro-to-highlight-expanding-clinical-uses-of-ultraclear-2910-nm-fiber-laser/2486381/Emerging clinical data on Acclaro’s UltraClear® 2910 nm fiber laser is set to be presented during multiple sessions at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado from March 26 through 31. The technology, a cold ablative fiber lase